top of page

Novartis CEO: Some Cancer Drugs Dropped From Pipeline Because of Medicare Price Negotiations


Novartis has dropped some early-stage cancer drugs from its pipeline because Medicare’s new ability to negotiate certain drug prices will make them no longer worthwhile for the company, according to...


We Work For Health brings together national and local business leaders, labor, biopharma, patient advocacy, and other healthcare-related stakeholders to support policies and initiatives that foster innovation and facilitate the delivery of lifesaving and life-enhancing medicines. 

We Work For Health. © 2023 All Rights Reserved.

Privacy

Terms of Use

bottom of page